The elevated expression of PRSS3 is associated with a poor prognosis for multiple cancers, including lung adenocarcinoma, gastric cancer, ductal carcinoma of the breast, and pancreatic cancer (37, 42–44). Here, PRSS3 is linked to breast ductal adenocarcinoma.